European Leukemia Trial Registry
Trial: CD-TCR-001

More Details
Scientific Title A Phase I/II, Open-Label, Non-Randomized, Multicentre, Dose-Escalation Clinical Trial with Control Group to Evaluate the Safety, Feasibility and Preliminary Efficacy of PRAME TCR Modified T Cells, MDG1011, in Subjects with High Risk Myeloid and Lymphoid Neoplasms
Short Title CD-TCR-001
Trialgroup NN
Type of Trial multicentric, single-group, prospective, open-label
Disease Myelodysplastic Syndrome(MDS) All subtypes
Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status Active
Start of Recruitment 28.11.2019
Leader Thomas, PD Dr. med., Simone
Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 09.01.2020 Student Studienregister
changed 09.01.2020 Student Studienregister
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |